Forensic Science International
Volume 157, Issue 1 , Pages 57-70 , 10 February 2006

A method for screening for various sedative-hypnotics in serum by liquid chromatography/single quadrupole mass spectrometry

Received 4 June 2004 ,Revised 18 February 2005 ,Accepted 7 March 2005.

References 

  1. Drummer OH. Methods for the measurement of benzodiazepines in biological samples. J. Chromatogr. B. 1998;713:201–225
  2. Inoue H, Maeno Y, Iwasa M, Matoba R, Nagao M. Screening and determination of benzodiazepines in whole blood using solid-phase extraction and gas chromatography/mass spectrometry. Forensic Sci. Int. 2000;113:367–373
  3. Borrey D, Meyer E, Lambert W, Van Calenbergh S, Van Peteghem C, De Leenheer AP. Sensitive gas chromatographic–mass spectrometric screening of acetylated benzodiazepines. J. Chromatogr. A. 2001;910:105–118
  4. Eap CB, Bouchoux G, Powell Golay K, Baumann P. Determination of picogram levels of midazolam, and 1- and 4-hydroxymidazolam in human plasma by gas chromatography–negative chemical ionization–mass spectrometry. J. Chromatogr. B. 2004;802:339–345
  5. Rittner M, Pragst F, Bork W-R, Neumann J. Screening method for seventy psychoactive drugs or drug metabolites in serum based on high-performance liquid chromatography–electrospray ionization mass spectrometry. J. Anal. Toxicol. 2001;25:115–124
  6. Venisse N, Marquet P, Duchoslav E, Dupuy JL, Lachâtre G. A general unknown screening procedure for drugs and toxic compounds in serum using liquid chromatography–electrospray-single quadrupole mass spectrometry. J. Anal. Toxicol. 2003;27:7–14
  7. Gergov M, Ojanperä I, Vuori E. Simultaneous screening for 238 drugs in blood by liquid chromatography–ionspray tandem mass spectrometry with multiple-reaction monitoring. J. Chromatogr. B. 2003;795:41–53
  8. Kratzsch C, Tenberken O, Peters FT, Weber AA, Kraemer T, Maurer HH. Screening, library-assisted identification and validated quantification of 23 benzodiazepines, flumazenil, zaleplone, zolpidem and zopiclone in plasma by liquid chromatography/mass spectrometry with atmospheric pressure chemical ionization. J. Mass Spectrom. 2004;39:856–872
  9. Smink BE, Brandsma JE, Dijkhuizen A, Lusthof KJ, de Gier JJ, Egberts AC, et al. Quantitative analysis of 33 benzodiazepines, metabolites and benzodiazepine-like substances in whole blood by liquid chromatography-(tandem) mass spectrometry. J. Chromatogr. B. 2004;811:13–20
  10. Marquet P. Is LC–MS suitable for a comprehensive screening of drugs and poisons in clinical toxicology?. Ther. Drug Monit. 2002;24:125–133
  11. Ohmae Y, Kanamori T, Iwata Y, Tsujikawa K, Kuwayama K, Inoue H, et al. Study on mixed-mode solid-phase extraction for drug screening in human serum. Jpn. J. Sci. Technol. Iden. 2004;9:71–78(abstract in English)
  12. Japan Pharmaceutical Information Center (Ed.), Drugs in Japan: Ethical Drugs, 28th ed., Jiho, Tokyo, 2004 (in Japanese).
  13. Japan Pharmaceutical Information Center (Ed.), Drugs in Japan: OTC-Drugs, 14th ed., Jiho, Tokyo, 2003 (in Japanese).
  14. Sternbach LH, Fryer RI, Metlesics W, Reeder E, Sach G, Saucy G, et al. Quinazolines and 1,4-benzodiazepines. VI. Halo-, methyl-, and methoxy-substituted 1,3-dihydro-5-phenyl-2H-1,4-benzodiazepine-2-ones. J. Org. Chem. 1962;27:3788–3796
  15. Adachi Y, Takahashi T. Forensic identification of drugs and toxic substances by liquid chromatography–electrospray ionization/mass spectrometry. J. Mass Spectrom. Soc. Jpn. 2004;52:39–44(abstract in English)
  16. Bonfiglio R, King RC, Olah TV, Merkle K. The effects of sample preparation methods on the variability of the electrospray ionization response for model drug compounds. Rapid Commun. Mass Spectrom. 1999;13:1175–1185
  17. Gorecki DKJ, Hindmarsh KW, Hall CA, Mayers DJ. Determination of chloral hydrate metabolism in adult and neonate biological fluids after single-dose administration. J. Chromatogr. 1990;528:333–341
  18. Sellers EM, Lang-Sellers M, Koch-Weser J. Comparative metabolism of chloral hydrate and triclofos. J. Clin. Pharmacol. 1978;18:457–461
  19. Lavene D, Abriol C, Guerret M, Kiechel JR, Lallemand A, Rulliere R. Pharmacokinetics of cloxazolam in man, after single and multiple oral doses. Thérapie. 1980;35:533–543
  20. Shindo H, Hayashi R, Ariga T, Totsu J. Pharmacokinetics and urinary metabolites of haloxazolam (CS-430) in man (author's translation). Yakuri To Chiryo. 1980;8:4551–4567(in Japanese)
  21. Higa Y, Watanabe R. Clinical pharmacological study of anxiolytic drug CS-386 (author's translation). Shinryo To Shinyaku. 1979;16:984–1000(in Japanese)
  22. Yamazaki Y, Iwai T, Ninomiya T, Kawahara Y. Pharmacokinetics in man following oral administration of oxazolam. Ann. Rep. Sankyo Res. Lab. 1980;32:104–113
  23. Kobari T, Namekawa H, Ujiie A. Pharmacokinetics of MS-4101 in man (author's translation). Yakuri To Chiryo. 1978;6:1679–1688(in Japanese)
  24. Yamaguchi T, Nakanishi M, Yamashita M, Matsumoto H, Nakamura M, Kominami G, et al. Pharmacology of a new sleep-inducer, 1H-1,2,4-triazolyl benzophenone derivative, 450191-S (VIII). Examination and determination of metabolites in human plasma and urine. Folia Pharmacol. Jpn. 1987;90:239–247(abstract in English)
  25. Davi H, Guyonnet J, Sales Y, Cautreels W. Metabolism of ethyl loflazepate in the rat, the dog, the baboon and in man. Arzneim. Forsch. 1985;35:1061–1065
  26. Hasegawa M, Matsubara I. Metabolic fates of flurazepam. I. Gas chromatographic determination of flurazepam and its metabolites in human urine and blood using electron capture detector. Chem. Pharm. Bull. (Tokyo). 1975;23:1826–1833
  27. Barzaghi N, Leone L, Monteleone M, Tomasini G, Perucca E. Pharmacokinetics of flutoprazepam, a novel benzodiazepine drug, in normal subjects. Eur. J. Drug Metab. Pharmacokinet. 1989;14:293–298
  28. Interview Form (Manufacturer's Brochure) of Erispan, Sumitomo Pharmaceuticals, Osaka, Japan, 1998 (in Japanese)
  29. Zampaglione N, Hilbert JM, Ning J, Chung M, Gural R, Symchowicz S. Disposition and metabolic fate of 14C-quazepam in man. Drug Metab. Dispos. 1985;13:25–29
  30. Shader RI, Pary RJ, Harmatz JS, Allison S, Locniskar A, Greenblatt DJ. Plasma concentrations and clinical effects after single oral doses of prazepam, clorazepate, and diazepam. J. Clin. Psychiatry. 1984;45:411–413
  31. Ochs HR, Greenblatt DJ, Verburg-Ochs B, Locniskar A. Comparative single-dose kinetics of oxazolam, prazepam, and clorazepate: three precursors of desmethyldiazepam. J. Clin. Pharmacol. 1984;24:446–451
  32. Viukari M, Linnoila M. Serum medazepam, diazepam, and N-desmethyldiazepam levels after single and multiple oral doses of medazepam. Ann. Clin. Res. 1977;9:284–286
  33. Dixon R, Brooks MA, Postma E, Hackman MR, Spector S, Moore JD, et al. N-Desmethyldiazepam: a new metabolite of chlordiazepoxide in man. Clin. Pharmacol. Ther. 1976;20:450–457
  34. Humpel M, Illi V, Milius W, Wendt H, Kurowski M. The pharmacokinetics and biotransformation of the new benzodiazepine lormetazepam in humans. I. Absorption, distribution, elimination and metabolism of lormetazepam-5-14C. Eur. J. Drug Metab. Pharmacokinet. 1979;4:237–243
  35. Shader RI, Greenblatt DJ, Harmatz JS, Franke K, Koch-Weser J. Absorption and disposition of chlordiazepoxide in young and elderly male volunteers. J. Clin. Pharmacol. 1977;17:709–718
  36. Yanagi Y, Haga F, Endo M, Kitagawa S. Comparative metabolic study of nimetazepam and its desmethyl derivative (nitrazepam) in dogs. Xenobiotica. 1976;6:101–112
  37. Nguyen KT, Stephens DP, McLeish MJ, Crankshaw DP, Morgan DJ. Pharmacokinetics of thiopental and pentobarbital enantiomers after intravenous administration of racemic thiopental. Anesth. Analg. 1996;83:552–558

PII: S0379-0738(05)00171-4

doi: 10.1016/j.forsciint.2005.03.011

Forensic Science International
Volume 157, Issue 1 , Pages 57-70 , 10 February 2006

Article Tools

* Image Usage & Resolution